Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Retinoblastoma 1Neuroblastoma 1Glioma 1

Interventions

racotumomab 1entinostat 1Thiotepa 1Thalidomide 1Tamoxifen 1Sirolimus 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1LY2940680 1Immunotherapy, Adoptive 1Immunologic Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Erlotinib Hydrochloride 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × racotumomab × Other solid neoplasm × Clear all
NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed
15 enrolled
CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡